Products



Product Information
Video Series


Download our FREE Email
Marketing Guide


"Quick, efficient deployment of emails. Good advice and true partnership to help my project succeed."

Jonathan Kalan, Kalan & Associates

"The email looked great! Thanks for the terrific service you provide us. I appreciate it."

Elizabeth Fitzsimons, Rady Children's Hospital — San Diego

"You and your team are an absolute joy to work with. I will strongly recommend to my colleagues to utilize your services."

Leanne Funada, UC Irvine Medical Center

"HDS is very responsive to all of our count request and order needs. I appreciate the quick turnaround."

Jennifer O'Brien, Response Solutions

"HDS has great pricing and a willingness to work within our budget. Great flexibility."

David Marciniak, GfK Healthcare

"Great follow-up, responding to requests quickly, understanding exactly what we are trying to do in order to understand context of needs."

Bryan Rickelman, Emergency Staffing Solutions

"The entire experience was great. I am a difficult customer and had many questions. HDS answered them with professionalism and patience."

Sandra McElwee, The Referral Specialists

"The HDS Team is flexible in ensuring that the data models are a perfect fit for what we need and that the products maximize our ability to reach decision makers and market efficiently."

Douglas Stitzer, Medical Protective

"We interviewed several sources for our data, and we went with HDS because they had the best quality, most dependable data."

Brian Hogan, CEO, LifeScript

The Fourth Annual Summit on Disclosure Transparency and Aggregate Spend for Drug, Device and Biotech Companies

Washington, DC

The Fourth Annual Summit on Disclosure Transparency and Aggregate Spend for Drug, Device and Biotech Companies will offer pharmaceutical and medical device professionals with the first opportunity to discuss and exchange practical experience since the launch of the January 1, 2012 Sunshine Act. Experts will share their personal experience and the conference will provide advice on operational questions that companies are currently facing. Third parties, senior regulators from state and federal agencies will also weigh in on questions and concerns.